Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asoprisnil in Uterine Leiomyomata
NCT00160381Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asoprisnil in uterine leiomyoma, sponsored by Abbott Laboratories. Started Sep 2002; status: completed.
02
Drugs
asoprisnil
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00160381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160381.